A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma von Jagannath, S., Barlogie, B., Berenson, J., Siegel, D., Irwin, D., Richardson, P. G., Niesvizky, R., Alexanian, R., Limentani, S. A., Alsina, M., Adams, J., Kauffman, M., Esseltine, D.‐L., Schenkein, D. P., Anderson, K. C.

Volltext

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa stu... von Martin, M., Fumoleau, P., Dewar, J.A., Albanell, J., Limentani, S.A., Campone, M., Chang, J.C., Patre, M., Strasak, A., de Haas, S.L., Xu, J., Garcia-Saenz, J.A.

Volltext

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer von Gradishar, W.J., Wedam, S.B., Jahanzeb, M., Erban, J., Limentani, S.A., Tsai, K.-T., Olsen, S.R., Swain, S.M.

Volltext

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study von Blackstock, A W, Mornex, F, Partensky, C, Descos, L, Case, L D, Melin, S A, Levine, E A, Mishra, G, Limentani, S A, Kachnic, L A, Tepper, J E

Volltext

Binding of Human Plasminogen and Urokinase-Type Plasminogen Activator to the Lyme Disease Spirochete, Borrelia burgdorferi von Klempner, Mark S., Noring, Richard, Epstein, Mark P., McCloud, Bruce, Hu, Rong, Limentani, Steven A., Rogers, Rick A.

Volltext

A practical guide to the evaluation and treatment of hemophilia von FURIE, B, LIMENTANI, S. A, ROSENFIELD, C. G

Volltext

Acquired free protein S deficiency associated with multiple myeloma: A case report von Deitcher, Steven R., Erban, John K., Limentani, Steven A.

Volltext

Immunoaffinity Purification of Factor IX (Christmas Factor) by Using Conformation-Specific Antibodies Directed against the Factor IX-Metal Complex von Liebman, Howard A., Limentani, Steven A., Furie, Barbara C., Furie, Bruce

Volltext

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma von Richardson, Paul G, Barlogie, Bart, Berenson, James, Singhal, Seema, Jagannath, Sundar, Irwin, David, Rajkumar, S. Vincent, Srkalovic, Gordan, Alsina, Melissa, Alexanian, Raymond, Siegel, David, Orlowski, Robert Z, Kuter, David, Limentani, Steven A, Lee, Stephanie, Hideshima, Teru, Esseltine, Dixie-Lee, Kauffman, Michael, Adams, Julian, Schenkein, David P, Anderson, Kenneth C

Volltext

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial von Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Volltext

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa stu... von Martin, M, Fumoleau, P, Dewar, J A, Albanell, J, Limentani, S A, Campone, M, Chang, J C, Patre, M, Strasak, A, de Haas, S L, Xu, J, Garcia-Saenz, J A

Volltext

Recombinant Blood Clotting Proteins for Hemophilia Therapy von Limentani, Steven A., Roth, David A., Furie, Barbara C., Furie, Bruce

Volltext

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial von Mackey, John R, Prof, Martin, Miguel, Prof, Pienkowski, Tadeusz, Prof, Rolski, Janusz, MD, Guastalla, Jean-Paul, MD, Sami, Amer, MD, Glaspy, John, MD, Juhos, Eva, MD, Wardley, Andrew, MD, Fornander, Tommy, MD, Hainsworth, John, MD, Coleman, Robert, MD, Modiano, Manuel R, MD, Vinholes, Jeferson, MD, Pinter, Tamas, MD, Rodríguez-Lescure, Álvaro, MD, Colwell, Bruce, MD, Whitlock, Pierre, MD, Provencher, Louise, MD, Laing, Kara, MD, Walde, David, MD, Price, Chris, MD, Hugh, Judith C, MD, Childs, Barrett H, MD, Bassi, Kimberly, BS, Lindsay, Mary-Ann, PharmD, Wilson, Véronique, MSc, Rupin, Matthieu, MSc, Houé, Vincent, MSc, Vogel, Charles, MD

Volltext

Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I... von SOCINSKI, Mark A, MORRIS, David E, DETTERBECK, Frank C, ROSENMAN, Julian G, HALLE, Jan S, MOORE, Dominic T, HENSING, Thomas A, LIMENTANI, Steven A, FRASER, Robert, TYNAN, Maureen, MEARS, Andrea, RIVERA, M. Patricia

Volltext

Will recent innovations in therapy save perceived deficiencies in self-sufficiency policies von Limentani, S A

Volltext

A phase I dose-escalation and pharmacokinetic (PK) evaluation of an oral AKT inhibitor, LY2503029 (LY) von Limentani, S. A., Burris, H., Anderson, A. P., Brail, L. H., Satonin, D., Gueorguieva, I., Jones, S., Infante, J. R., Bendell, J. C.

Volltext

Separation of Human Plasma Factor IX From HTLV-I or HIV by Immunoaffinity Chromatography Using Conformation-Specific Antibodies von Limentani, Steven A., Furie, Barbara C., Poiesz, Bernard J., Montagna, Richard, Wells, Keith, Furie, Bruce

Volltext

Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all‐trans retinoic acid von Limentani, Steven A., Pretell, Judith O., Potter, David, Dubois, Jon S., Daoust, Philip R., Spieler, Paul S., Miller, Kenneth B.

Volltext

A randomized, placebo-controlled phase II study of AMG 386 plus bevacizumab (Bev) and paclitaxel (P) or AMG 386 plus P as first-line therapy in patients (pts) with HER2-negative, l... von Dieras, V., Jassem, J., Dirix, L. Y., Guastalla, J. P., Bono, P., Hurvitz, S. A., Gonçalves, A., Romieu, G., Limentani, S. A., Jerusalem, G. H. M., Lakshmaiah, K., Roche, H. H., Sánchez-Rovira, P., Pienkowski, T., Seguí-Palmer, M. A., Li, A., Sun, Y., Pickett-Gies, C. A., Wildiers, H.

Volltext

Safety and efficacy of neratinib (HKI-272) in combination with vinorelbine in patients with solid tumors von Limentani, S. A., Awada, A., Dirix, L., Beck, J., Dieras, V., Binlich, F., Germa, C., Agrapart, V., Powell, C., Hershman, D.

Volltext